This is the authors' abstract. We don't add key points for this paper.
Objectives: Thousands of Veterans file claims for military sexual trauma (MST)-related posttraumatic stress disorder (PTSD) disability through the Department of Veterans Affairs' (VA) Veterans Benefits Administration (VBA) annually to receive covered healthcare benefits and monthly nontaxable compensation for MST-related conditions. Although 72% of MST claims in 2021 were granted, prior reporting found claims had been erroneously denied due to insufficient evidence-gathering and scheduling of disability exams for sufficiently developed claims. The present study explores decision-making processes around evidence-gathering for MST-related disability claims through interviews with VBA and Veterans Health Administration (VHA) staff who develop, rate, and evaluate MST disability claims ( n = 21). Methods: Interviews occurred from October 2021-January 2024 and were analyzed using rapid qualitative methods and inductive coding, revealing themes of ambiguity, beliefs, and discretion. Results: Participants described MST "markers"(e.g., behavioral events or patterns indicating effects of MST) as difficult to reliably identify and demonstrated disagreements about what constituted a marker. Within this ambiguity, factors that shaped participants' decision-making included beliefs about the MST and its impacts, the veracity of Veteran PTSD and/or MST claims, and the role of VA staff. Participants' judgments appeared to depend in part on personal beliefs; those who generally believed Veterans advocated for and centered survivors, whereas those who endorsed sexual assault myths or that Veterans were not truthful about PTSD and/or MST were skeptical and tended to gatekeep VA resources for those deserving. Conclusion: Future policy and programming around MST claim processing should focus on reducing ambiguity and impacts of personal beliefs on discretion and objectivity.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Webermann et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: